Top Medical News
11 hours ago
Endurance exercise appears to have a direct effect on serum 25-hydroxyvitamin D (25[OH]D) concentrations, according to a new study. Moreover, sex disparity exists in the serum 25(OH)D response to acute endurance exercise, and men have greater increase in 25(OH)D concentrations than women.
Yesterday
Individuals who eat fibre-rich food are likely to have lower postprandial glucose at breakfast, a recent study has found. In addition, the consumption of soluble fibre from food and supplement has a similar beneficial effect in patients with type 2 diabetes (T2D).
Yesterday
Moderate increases in physical activity levels may translate to significant reductions in both fasting glucose and HbA1c, a study has found.
2 days ago
Physical activity interventions confer benefits for fasting glucose and HbA1c, and such benefits appear to depend on the duration of exercise per week rather than the type of physical activity, according to a study.
4 days ago
Close to 50 percent of diabetic patients with dysphagia are found to have some type of an oesophageal motility disorder, according to a new study. Moreover, diabetic retinopathy and insulin use among diabetic patients are risk factors for oesophageal motor abnormalities.
Roshini Claire Anthony, 5 days ago

A once-a-month intramuscular injection of pasireotide has shown promise in reducing cortisol levels in patients with pituitary-related Cushing’s disease, a recent phase III study found. 

Roshini Claire Anthony, 6 days ago

Patients with rheumatoid arthritis (RA) who are overweight or obese have a higher degree of histologically-proven follicular synovitis. Furthermore, body mass index (BMI) appears to impact response to treatment in these patients, according to a study presented at the annual meeting of the ACR/ARHP* held in San Diego, California, US.

 

Special Reports
05 Apr 2017
At a recent lunch symposium held in conjunction with the 1st Malaysian Advances in Women’s Health Congress 2016, Professor Dr Jamiyah Hassan imparted clinical updates and strategies for the optimization of hormone replacement therapy in menopausal women. Highlights from her presentation are summarized below.
16 Mar 2017
Recently, Dr Peter Lin of the Canadian Heart Research Centre spoke on treatment strategies in the management of dyslipidaemia and T2DM at an AstraZeneca-sponsored continuing medical education event. Highlights of his presentations are summarized below.
20 Jan 2017
At the recent Malaysian Osteoporosis Society 2016 Clinical Practice Guideline (CPG) Meeting held on the 8th of October 2016 at Ibis Styles Ipoh, Dr Hew Fen Lee and Professor Dr Chan Siew Pheng presented clinical guidance on the management of osteoporosis, and discussed whether the benefits of treatment outweigh the risks.
04 Jan 2017
At the Diabetes Asia 2016 Conference organized by the National Diabetes Institute, Professor Jean Claude Mbanya presented the case for why gliclazide modified release (MR; Diamicron® MR, Servier) should be the treatment of choice for early and aggressive control of type 2 diabetes (T2D).
16 Dec 2016
BASALOG – Insulin glargine (rDNA) 100 IU/mL soln for inj (cartridge) – CCM Pharmaceuticals
16 Dec 2016
INVOKANA – Canagliflozin hemihydrate 100 mg and 300 mg FC tab – Johnson & Johnson (Janssen)
Pearl Toh, 07 Dec 2016
Preventing hypertension, diabetes, and obesity, which are the major risk factors for heart failure (HF), by ages 45 and 55 years may lower risks of incident HF and prolong HF-free survival, suggests data from the Cardiovascular Disease Lifetime Risk Pooling Project.
Conference Reports
Pearl Toh, 07 Oct 2017
Older age, presence of multiple comorbidities, and longer length of hospital stay, rather than difference in glycaemic control, were associated with an increased risk of 1-year death following admission with severe hypoglycaemia in patients with diabetes, according to a Singapore study.
Elaine Soliven, 02 Oct 2017
The use of continuous glucose monitoring (CGM) is associated with a decreased amount of time spent in hypoglycaemia in patients with type 1 diabetes (T1D), according to a study presented at EASD 2017.
Pearl Toh, 01 Oct 2017
Adding continuous glucose monitoring (CGM) to conventional finger-prick test during pregnancy increases the time spent in the recommended glycaemic target range and improves neonatal health outcomes in patients with type 1 diabetes (T1D) compared with traditional test alone, according to the CONCEPTT* study presented at EASD 2017.
Pearl Toh, 27 Sep 2017
Dapagliflozin improves glycaemic control with sustained weight loss without an increased risk of diabetic ketoacidosis (DKA) in patients with type 1 diabetes (T1D) who are inadequately controlled with insulin, according to the DEPICT-1* study.
Roshini Claire Anthony, 26 Sep 2017

Once-weekly doses of the glucagon-like peptide-1 receptor agonist exenatide plus insulin glargine improved glucose control and weight loss in patients whose type 2 diabetes (T2D) was uncontrolled on basal insulin and metformin, according to findings from the DURATION-7* trial.

Audrey Abella, 26 Sep 2017
The novel, G-protein coupled receptor 119 (GPR119) agonist DS-8500a demonstrated dose-dependent glucose-lowering effects and favourable improvements in lipid parameters that extended up to 12 weeks in Japanese patients with type 2 diabetes mellitus (T2D), according to data presented at EASD 2017.
25 Sep 2017
Podcast: Prof Melanie Davies talks about the novel dual SGLT1/2 inhibitor sotagliflozin for T1D
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD